Wednesday, December 11, 2024

What lies ahead for Sanders’ likely last term

Presented by CVS Health: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Dec 11, 2024 View in browser
 
POLITICO Pulse Newsletter Header

By Chelsea Cirruzzo and Ben Leonard

Presented by 

CVS Health
Driving the Day

Bernie Sanders descends on an escalator.

Sen. Bernie Sanders has hinted that he probably won't run for reelection after his current term is up. | Francis Chung/POLITICO

SANDERS’ FINAL STAND — Progressive leader and former presidential candidate Sen. Bernie Sanders has six more years in the Senate ahead of him — and they’re likely to be his last, the Vermont lawmaker told POLITICO’s Daniel Payne.

When asked whether his fourth Senate term would be his last, Sanders (I-Vt.) said: “I’m 83 now. I’ll be 89 when I get out of here. You can do the figuring. I don’t know, but I would assume, probably, yes.”

Sanders has been in Congress since 1991. He served eight House terms before winning election to the Senate in 2006 and, though he has long touted his independence from party affiliation, was a leading contender for the Democratic presidential nomination in 2016 and 2020. He was runner-up both times.

Sanders helped move the Democratic caucus in the Senate to the left but is concerned about the future of progressive ideals in American politics.

Sanders added that many Americans appreciate what the Biden administration has done to lower drug prices and improve infrastructure. But he continues to rail against currents in the party that he says are out of touch with the American working class.

Not even everyone in Congress’ Progressive Caucus fully understands the vision needed for the party’s future, according to Sanders.

“Some do and some don’t,” he said.

But Sanders said he takes heart that the Progressive Caucus, which Sanders first formed with five other members in 1991, has grown to more than 100.

“Dozens of them are really strong progressives who share my perspectives,” he said.

Sanders will lose his chair at the Health, Education, Labor and Pensions Committee in January but said he hopes to return to the post if Democrats can retake control of the Senate.

He said his record leading the committee includes expanding primary care funding and holding leaders of pharmaceutical companies to account for charging higher prices in the U.S. compared to other countries.

“We are the only major country on Earth that doesn’t guarantee health care to all of its people. And we pay the highest prices in the world for prescription drugs,” he said. “My vision is pretty clear as to where we have to go.”

WELCOME TO WEDNESDAY PULSE. We’ll only be in your inboxes for another two weeks before we go on break for the holidays, so if there’s a scoop you’ve been dying to send over, now’s the time to ccirruzzo@politico.com and bleonard@politico.com and follow along @ChelseaCirruzzo and @_BenLeonard_.

A message from CVS Health:

CVS Health works every day to put medicine within reach of people who need it. Our patients have an average out-of-pocket cost of less than $8 for a 30-day supply of medication, and last year nearly 70% of members spent less than $100 out-of-pocket on prescriptions. Learn more about how we’re ensuring access to affordable medications for millions of Americans.

 
In Congress

Robert F. Kennedy Jr. arrives to a hearing.

The appointment of Robert F. Kennedy Jr. as HHS secretary likely hinges on the votes of three Republican senators. | Anna Moneymaker/Getty Images

RFK IN TROUBLE — Robert F. Kennedy Jr.’s prospects of becoming HHS secretary could be dimming as at least three GOP senators are noncommittal about confirming the vaccine critic, POLITICO’s Ursula Perano reports.

Those include swing votes like Sens. Susan Collins of Maine, Lisa Murkowski of Alaska and Bill Cassidy of Louisiana, a gastroenterologist who will chair a committee that could host confirmation hearings for Kennedy.

When asked whether Kennedy’s past controversies would bog down his nomination, Cassidy said everyone wants to “predict the future,” but he just wants to “let things play.”

Why their votes matter: Kennedy can afford to lose only three Republicans during his confirmation if all Senate Democrats vote against him.

Some aren’t timid in sharing their thoughts. Sen. Chris Murphy (D-Conn.), a member of the Senate Health, Education, Labor and Pensions Committee, said he doesn’t want a “denier of science” helming the nation’s top health agency.

“I get that there are quid pro quos in politics, but that one’s a pretty naked one,” Murphy said.

And a GOP senator, granted anonymity to speak candidly, last week suggested Kennedy might be the next of Trump’s nominees to face problems in the Senate. They noted that goodwill from Democrats toward the nominee may even “hurt” his chances with Republicans.

What to watch: Kennedy is expected on Capitol Hill next week with nearly two dozen meetings scheduled, per a spokesperson.

“This is a week going after Tulsi Gabbard. Now, I guess they’re gonna skip over Kash [Patel] and then go after RFK next week because he’s coming,” said Sen. Tommy Tuberville (R-Ala.), who said he’s meeting with Kennedy on Tuesday. Tuberville broadly supports Trump’s picks for nominees and said Kennedy has “got a lot of great ideas” and is “outside the box.”

GUTHRIE LOOKS FORWARD — Rep. Brett Guthrie (R-Ky.), incoming chair of the Energy and Commerce Committee, told reporters Tuesday that crafting a reconciliation package will be a top priority.

The maneuver, which allows lawmakers to skirt the Senate filibuster and pass legislation with a simple majority in both chambers, will be a major focus for enacting President-elect Donald Trump’s agenda. Guthrie didn’t go into details about the package’s contents, saying he hasn’t been involved since he isn’t yet chair.

“Hopefully, we’ll get started on it very soon,” Guthrie said.

Guthrie noted Trump said he wouldn’t touch Medicare or Social Security. Republicans have suggested making changes to Medicaid as part of reconciliation could help pay for other priorities.

Guthrie said he’s always supported per capita allotments for Medicaid, which could lead to lower Medicaid spending by allocating money based on population, not the cost of care.

“It doesn’t cut Medicaid,” Guthrie said. “It allows Medicaid to grow … if you lose population, you lose money, and if you gain population, you gain.”

Asked whether he would pursue changes to the Affordable Care Act, Guthrie said we’re “looking at everything.” Despite there not being a bill to repeal and replace Obamacare, he said there are things that “we have to fix,” including costs.

He noted that enhanced ACA premium subsidies run out at the end of 2025. Republicans are expected to let them expire, though insurers and other groups are pushing to keep them going. He said it would be a conference decision about whether to continue them but suggested they drive up health care spending.

The Congressional Budget Office has estimated that the subsidies’ expiration would lead to millions more uninsured Americans.

He signaled openness to bolstering association health plans, which Trump-era rules expanded access to, making it easier for small businesses to team up to buy health insurance and avoid some regulations.

About that end-of-year health care package: Guthrie said the situation is fluid. Democrats and Republicans have traded offers.

HAIL MARY FOR SOCIAL MEDIA BILL — House Speaker Mike Johnson is holding a Senate-passed bill requiring social media companies to do more to protect kids online, saying it “might lead to further censorship by the government of valid conservative voices” and calling for more negotiation, POLITICO’s Ruth Reader reports.

On Saturday, principal GOP Senate sponsor, Tennessee’s Marsha Blackburn, made changes to the Kids Online Safety Act in a last-ditch effort to get it passed

But Johnson has softened his “no,” saying if an agreement weren’t possible this year, Republicans could take up the measure again in 2025. “All of us, a hundred percent of us, support the principle behind it, but you've got to get this one right,” he said.

Why it matters: Blackburn’s bill would create a “duty of care” requiring social media firms to alter design features that addict kids and allow unwanted contact with strangers.

She suggested changes that would limit the regulation of platform design so it applies only to personalized features and limit the duty of care to only harms related to features that stoke compulsive usage.

Johnson hasn’t relented despite a lobbying campaign that includes parents, advocacy groups, Surgeon General Vivek Murthy and attorneys general in more than 35 states.

He said waiting till the next Congress, when Republicans will control both chambers and the White House, would speed negotiations. But that might effectively kill the bill.

Tech industry opponents of the bill want to eliminate the duty-of-care language, arguing it could force them to suppress content.

What’s next: Parents groups that support KOSA demonstrated on Capitol Hill on Tuesday and still hope to convince lawmakers to attach the bill to end-of-year spending legislation.

AROUND THE AGENCIES

RSV VAX TRIALS PAUSED — Moderna is putting its studies of two RSV vaccine candidates in infants and young children on hold after reports of severe lower respiratory tract infections, the FDA said Tuesday, POLITICO’s Lauren Gardner reports.

Why it matters: Vaccine development for respiratory syncytial virus in young children was dormant for decades after a candidate tested in the 1960s led to more severe disease in vaccinated children once they were naturally exposed to the virus, with two toddlers dying. But the pipeline has picked up in recent years as technology has advanced and three vaccines received FDA approval for adults.

What happened: Moderna’s study of two vaccine candidates for RSV in babies ages 5 to 8 months saw an imbalance of severe and very severe infections among those not in the placebo group.

Moderna, which is developing several vaccines with its messenger RNA technology, said in September it didn’t expect its RSV vaccine for children under 2 “to advance beyond the ongoing Phase [I trial] based on emerging clinical data” but didn’t offer more details.

What’s next: The agency’s external vaccine advisers meet Thursday to discuss safety concerns and potential precautions for studying RSV vaccines in young children.

 

A message from CVS Health:

Advertisement Image

 
Names in the News

Dr. Kelvin Choi is now scientific director of the National Institute on Minority Health and Health Disparities’ Division of Intramural Research. He’s been acting director since the retirement of Dr. Anna M. Nápoles in March. 

WHAT WE'RE READING

POLITICO’s Joshua Zeitz reports on a theory about why some people are celebrating the suspected United Healthcare CEO killer.

CNN reports on draft federal recommendations endorsing HPV testing as the preferred screening for cervical cancer.

POLITICO’s Katherine Tully-McManus, Ursula Perano and Anthony Adragna report that Senate Minority Leader Mitch McConnell cut his face and sprained his wrist after a fall on Capitol Hill.

A message from CVS Health:

CVS Health is improving the lives of hundreds of millions of people every day, simplifying their health care journey and reducing the cost of prescription drugs. Our patients have an average out-of-pocket cost of less than $8 for a 30-day supply of medication, and last year nearly 70% of members spent less than $100 out-of-pocket on prescriptions. We’re actively working to bring down costs for plan sponsors and their members, all while ensuring access to critical medications for millions of Americans.

Learn more about how we’re making medicine more affordable for all Americans.

 
 

Follow us on Twitter

Dan Goldberg @dancgoldberg

Chelsea Cirruzzo @chelseacirruzzo

Lauren Gardner @Gardner_LM

Sophie Gardner @sophie_gardnerj

Kelly Hooper @kelhoops

Robert King @rking_19

Ben Leonard @_BenLeonard_

David Lim @davidalim

Megan Messerly @meganmesserly

Alice Miranda Ollstein @aliceollstein

Carmen Paun @carmenpaun

Daniel Payne @_daniel_payne

Ruth Reader @RuthReader

Erin Schumaker @erinlschumaker

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

No comments:

Post a Comment

Surprise! MVP revives Smart Money

Competition is heating up in the Philippine e-wallet space ͏ ‌      ͏ ‌      ͏ ‌      ͏ ‌      ͏ ‌      ͏ ‌      ͏ ‌      ͏ ‌     ͏ ...